MedWatch

Danish company signs pact with Sanofi

What begun as a project funded by the Danish Advanced Technology Foundation is now receiving international attention, as it has captured the attention and wallet of French drug company, Sanofi.

Foto: Colourbox

The Danish contract research organisation, Gubra, has struck a development deal with Novo Nordisk’s French rival on the diabetes market, Sanofi.

The small Danish outfit thus follows in the footsteps of Zealand Pharma – and it all started as a small project backed by the Danish Advanced Technology Foundation (Højteknologifonden).

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier